Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu

A Study of the Effectiveness and Safety of Risperidone in the Treatment of Behavioral Disturbances in Patients With Dementia

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT00249145
Recruitment Status : Completed
First Posted : November 7, 2005
Last Update Posted : January 14, 2011
Sponsor:
Information provided by:
Janssen Pharmaceutica N.V., Belgium

No Study Results Posted on ClinicalTrials.gov for this Study
Recruitment Status : Completed
Primary Completion Date : No date given
Actual Study Completion Date : December 1996